Skip to main content
. 2020 Mar 3;35(15):e106. doi: 10.3346/jkms.2020.35.e106

Table 2. OWS according to the type of opioid analgesic.

Variables Remifentanil (n = 58) Fentanyl (n = 47) Morphine (n = 21) P value
OWS, No. (%; 95% CI) 18 (31.0; 20–43) 17 (36.2; 23–50) 2 (9.5; 2–28) 0.078
Withdrawal type 0.001
Discontinuation 20 (34.5) 32 (68.1) 15 (71.4)
De-escalation 38 (65.5) 15 (31.9) 6 (28.6)
OWS according to withdrawal type, No. (%; 95% CI)
OWS after discontinuation 7 (35.0; 18–56) 10 (31.3; 17–48) 2 (13.3; 3–37) 0.361
OWS after de-escalation 11 (28.9; 17–44) 7 (46.7; 24–69) 0 (0.0) 0.118
Duration of mechanical ventilation 7.0 (4.0–12.0) 10.0 (6.0–21.0)a 11.0 (2.5–19.5) 0.016
Total observation time, hr 18.8 ± 8.0 20.7 ± 6.0 22.3 ± 5.0 0.209
Duration of opioid infusion, days 5.5 (4.0–9.3) 5.0 (3.0–7.0) 6.0 (4.0–10.0) 0.456
Cumulative opioid dose, mg 5,023.8 (2,528.1–12,110.1) 2,090.4 (1,043.3–4,759.7)a 216.0 (48.0–588.0)a,b < 0.001
No. of symptoms 2.0 (1.0–4.0) 3.0 (2.0–4.0) 2.0 (1.0–3.5) 0.654

Results are reported as number (%), mean ± standard deviation, or median (interquartile range).

OWS = opioid withdrawal syndrome, CI = confidence interval.

avs. the remifentanil group; bvs. the fentanyl group.